Prognostic subgroup evaluations depicted in Figures 3(d), 3(e), and 3(f) corroborated that high PAX7 expression is linked to unfavorable prognosis in breast cancer (p < 0.05). This evidence concerns the gene PAX7 and breast carcinoma.